About Jennifer DeSimone, MD
Dr. Jennifer DeSimone is a specialty care physician board certified in dermatology. She joined Inova Medical Group with 5 years of clinical experience. She has a special interest in management of cutaneous lymphomas, skin cancer in organ transplant recipients and other complex skin cancers.
Most recently Dr. DeSimone served as a Director of Cutaneous Lymphoma. Dr. DeSimone became interested in lymphomas of the skin because of the rarity of the disease and the need for greater understanding of its origin and development of more effective therapy. Her goal is to help educate her patients about skin cancer etiology, management and importantly, prevention.
A native of Northern Virginia, Dr. DeSimone currently resides in Fairfax County with her husband and two children. In her spare time she enjoys cooking, entertaining, and trail running.
- Assistant Professor, Department of Dermatology Georgetown University Hospital
- United States Cutaneous Lymphoma Consortium
- American Society of Dermatologic Surgeons
- American Academy of Dermatology
- American Medical Association
- Top Docs, Washingtonian, 2020
Research and Publications
View list of publications from Dr. DeSimone's research
Blogs and Webcasts
Expert Panel Develops Guidance to Manage Skin Cancer in Organ Transplant Patients (October 2021)
CTCL: Criteria to Diagnose, Counsel Patients, and Work-Up for Early-stage Mycosis Fungoides (March 2023)
Medical EducationVirginia Commonwealth University School of Medicine 2005
Training Specialty: Internal Medicine
6/16/2005 - 06/30/2006
Training Specialty: Dermatology
07/01/2006 - 06/30/2010
Training Specialty: Cutaneous Oncology
7/1/2011 - 6/30/2012
About Patient Comments
The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.